Home

Lundbeck sites Contact Us

  • About Circadin
  • Key Publications
  • For your patients
  • Q & A
  • Prescribing Information
  • News
You are here: Home » About Circadin » Safety

Safety

Circadin has a favourable safety profile, with no obvious differences in safety parameters between the active treatment and the placebo group

Published: 01/07/2008   Last updated: 18/05/2010
Print  
  • About Circadin
    • Melatonin
      • Circadian clock
      • Melatonin with age
    • Circadin Efficacy
      • Circadin mimicks natural melatonin secretion
      • Circadin maintains sleep
      • Circadin shortens time to sleep
    • Quality of sleep
      • Significant improvement in QoS
      • Consistent improvement in QoS
      • Significant improvement in BFW
      • Concomitant improvement in QoS & BFW
    • Quality of life
      • Improvement of daytime functioning
      • Significant improvement in QoL
      • 70% experienced improvement in QoL
    • Safety
      • No dependency or withdrawal symptoms
      • Favourable safety profile
      • No contra-indications
    • Related links

Literature Search


 
  • About Circadin
  • Key Publications
  • For your patients
  • Q & A
  • Prescribing Information
  • News

www.irecover.com www.cipralex.com www.azilect.com www.serdolect.com www.depnet.com Disclaimer

H. Lundbeck A/S - Ottiliavej 9 - DK-2500 Copenhagen Valby - Phone +45 3630 1311 - Contact us

Lundbeck logo